InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Share Price

- Current share price for NSB : $0.054

NSB General Information +

ASX Code NSB
Website N/A
Industry/Sector n/a
Market Cap ($M) n/a
NSB Share Price $0.054
Day High $0.058
Day Low $0.052
Last Close $0.054
NSB Share Price Movement - ( No change )
Prices as at 14:51, 28 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

NeuroScientific Biopharmaceuticals Ltd (NSB) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from NeuroScientific Biopharmaceuticals Ltd (NSB) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

NeuroScientific Biopharmaceuticals Ltd (NSB) price-sensitive announcements

NSB - Quarterly Activities/Appendix 4C Cash Flow Report
NeuroScientific Biopharmaceuticals Limited’s Quarterly Activities Report and Appendix 4C f
NeuroScientific Biopharmaceuticals Ltd (NSB)
27 Oct 2026 | 9:08 AM
NSB - Leading CRO Appointed for Phase 2 Crohn's Trial
NeuroScientific Biopharmaceuticals Ltd announced on 1 October 2026 that it has appointed S
NeuroScientific Biopharmaceuticals Ltd (NSB)
1 Oct 2026 | 9:38 AM
NSB - 2026 Annual Report & Appendix 4E
NeuroScientific Biopharmaceuticals Limited (ASX: NSB) released its Appendix 4E and 2026 An
NeuroScientific Biopharmaceuticals Ltd (NSB)
25 Aug 2026 | 5:52 PM
NSB - Quarterly Activities/Appendix 4C Cash Flow Report
NeuroScientific Biopharmaceuticals Ltd announced positive developments in their ongoing ac
NeuroScientific Biopharmaceuticals Ltd (NSB)
28 Jul 2026 | 10:02 AM

NeuroScientific Biopharmaceuticals Ltd (NSB) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
NeuroScientific Biopharmaceuticals Ltd (NSB)
ORDINARY FULLY PAID
Health Care - Quarterly Activities/Appendix 4C Cash Flow Report 27 Oct 2026 9:08AM $0.052 $0.054 risen by 3.85%
NeuroScientific Biopharmaceuticals Ltd (NSB)
ORDINARY FULLY PAID
Health Care - Appointment of CFO 22 Oct 2026 9:31AM $0.060 $0.054 fallen by 10%
NeuroScientific Biopharmaceuticals Ltd (NSB)
ORDINARY FULLY PAID
Health Care - Results of Annual General Meeting 15 Oct 2026 1:52PM $0.061 $0.054 fallen by 11.48%
NeuroScientific Biopharmaceuticals Ltd (NSB)
ORDINARY FULLY PAID
Health Care - US FDA Provides Positive Feedback on Planned Phase 2 Trial 13 Oct 2026 9:31AM $0.058 $0.054 fallen by 6.90%
NeuroScientific Biopharmaceuticals Ltd (NSB)
ORDINARY FULLY PAID
Health Care - Leading CRO Appointed for Phase 2 Crohn's Trial 1 Oct 2026 9:38AM $0.061 $0.054 fallen by 11.48%
NeuroScientific Biopharmaceuticals Ltd (NSB)
ORDINARY FULLY PAID
Health Care - Notice of Annual General Meeting & Proxy Form 8 Sep 2026 3:59PM $0.062 $0.054 fallen by 12.90%

NSB Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
NeuroScientific Biopharmaceuticals Ltd (NSB) $21M 0.0556 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

NeuroScientific Biopharmaceuticals Ltd (NSB) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
27 Jun 2025 UVAROV, Anton Issued Options 1,000,000 $0.000 $100.000
27 Jun 2025 BARLOW, Clarke Issued Options 1,000,000 $0.000 $100.000
27 Jun 2025 UVAROV, Anton Issued Direct Shares 2,650,000 $0.035 $92,750.000

See all changes in directors' interest & trades for NeuroScientific Biopharmaceuticals Ltd (NSB) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.